Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Metronidazole in Colorectal Cancer
NCT05748145Phase 2Recruiting
- Sponsor
- Istituto Oncologico della Svizzera Italiana
- Start
- Sep 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of metronidazole in colorectal cancer (CRC), sponsored by Istituto Oncologico della Svizzera Italiana. Primary endpoint: Impact of metronidazole on F.n. loads in CRC tissues. Started Sep 2023; status: recruiting.
02
Drugs
metronidazole
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05748145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05748145.